Tomasz Arodz

Tomasz Arodz

Auto-generated profile, based on publicly available information

Tomasz Arodz

Virginia Commonwealth University

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in BMC Systems Biology
Verified
Journal Article
Open access
PDF file
JSJanusz Sławek
Janusz Sławek
TATomasz Arodź
Tomasz Arodź
The regulation of gene expression by transcription factors is a key determinant of cellular phenotypes. Deciphering genome-wide networks that capture which transcription factors regulate which genes is one of the major efforts towards understanding and accurate modeling of living systems. However, reverse-engineering the network from gene expression profiles remains a challenge, because the data are noisy, high dimensional and sparse, and the regulation is often obscured by indirect connections.

1 February 2015 in New Journal of Physics
Verified
Journal Article
Open access
TATomasz Arodz
Tomasz Arodz
DBDanail Bonchev
Danail Bonchev

26 April 2012 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
PDF file
TATomasz Arodź
Tomasz Arodź
Przemysław Mieszko PłonkaPrzemysław Mieszko Płonka
Przemysław Mieszko Płonka

20 July 2022 in Cells
Verified
Journal Article
Open access
PDF file
YBYahya Bokhari
Yahya Bokhari
AAAreej Alhareeri
Areej Alhareeri
AAAbdulrhman Aljouie
Abdulrhman Aljouie
AAAziza Alkhaldi
Aziza Alkhaldi
MRMamoon Rashid
Mamoon Rashid
TATomasz Arodz
Tomasz Arodz
Cytogenetics laboratory tests are among the most important procedures for the diagnosis of genetic diseases, especially in the area of hematological malignancies. Manual chromosomal karyotyping methods are time consuming and labor intensive and, hence, expensive. Therefore, to alleviate the process of analysis, several attempts have been made to enhance karyograms. The current chromosomal image enhancement is based on classical image processing. This approach has its limitations, one of which is that it has a mandatory application to all chromosomes, where customized application to each chromosome is ideal. Moreover, each chromosome needs a different level of enhancement, depending on whether a given area is from the chromosome itself or it is just an artifact from staining. The analysis of poor-quality karyograms, which is a difficulty faced often in preparations from cancer samples, is time consuming and might result in missing the abnormality or difficulty in reporting the exact breakpoint within the chromosome. We developed ChromoEnhancer, a novel artificial-intelligence-based method to enhance neoplastic karyogram images. The method is based on Generative Adversarial Networks (GANs) with a data-centric approach. GANs are known for the conversion of one image domain to another. We used GANs to convert poor-quality karyograms into good-quality images. Our method of karyogram enhancement led to robust routine cytogenetic analysis and, therefore, to accurate detection of cryptic chromosomal abnormalities. To evaluate ChromoEnahancer, we randomly assigned a subset of the enhanced images and their corresponding original (unenhanced) images to two independent cytogeneticists to measure the karyogram quality and the elapsed time to complete the analysis, using four rating criteria, each scaled from 1 to 5. Furthermore, we compared the enhanced images with our method to the original ones, using quantitative measures (PSNR and SSIM metrics).

1 December 2018 in Physiological Measurement
Verified
Journal Article
Closed access
PDF file
XGXi Gao
Xi Gao
EPEmmanuel F Petricoin
Emmanuel F Petricoin
KWKevin R Ward
Kevin R Ward
SGStephanie R Goldberg
Stephanie R Goldberg
TDTherese M Duane
Therese M Duane
RDRobert F Diegelmann
Robert F Diegelmann
Objective : The healing of wounds is critical in protecting the human body against environmental factors. The mechanisms involving protein expression during this complex physiological process have not been fully elucidated. Approach : Here, we use reverse-phase protein microarrays (RPPA) involving 94 phosphoproteins to study tissue samples from tubes implanted in healing dermal wounds in seven human subjects tracked over two weeks. We compare the proteomic profiles to proteomes of controls obtained from skin biopsies from the same subjects. Main results : Compared to previous proteomic studies of wound healing, our approach focuses on wound tissue instead of wound fluid, and has the sensitivity to go beyond measuring only highly abundant proteins. To study the temporal dynamics of networks involved in wound healing, we applied two network analysis methods that integrate the experimental results with prior knowledge about protein–protein physical and regulatory interactions, as well as higher-level biological processes and associated pathways. Significance : We uncovered densely connected networks of proteins that are up- or down-regulated during human wound healing, as well as their relationships to microRNAs and to proteins outside of our set of targets that we measured with proteomic microarrays.

23 March 2020 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
YBYahya Bokhari
Yahya Bokhari
AAAreej Alhareeri
Areej Alhareeri
TATomasz Arodz
Tomasz Arodz
Background: Cancer is caused by genetic mutations, but not all somatic mutations in human DNA drive the emergence or growth of cancers. While many frequently-mutated cancer driver genes have already been identified and are being utilized for diagnostic, prognostic, or therapeutic purposes, identifying driver genes that harbor mutations occurring with low frequency in human cancers is an ongoing endeavor. Typically, mutations that do not confer growth advantage to tumors – passenger mutations – dominate the mutation landscape of tumor cell genome, making identification of low-frequency driver mutations a challenge. The leading approach for discovering new putative driver genes involves analyzing patterns of mutations in large cohorts of patients and using statistical methods to discriminate driver from passenger mutations. Results: We propose a novel cancer driver gene detection method, QuaDMutNetEx. QuaDMutNetEx discovers cancer drivers with low mutation frequency by giving preference to genes encoding proteins that are connected in human protein-protein interaction networks, and that at the same time show low deviation from the mutual exclusivity pattern that characterizes driver mutations occurring in the same pathway or functional gene group across a cohort of cancer samples. Conclusions: Evaluation of QuaDMutNetEx on four different tumor sample datasets show that the proposed method finds biologically-connected sets of low-frequency driver genes, including many genes that are not found if the network connectivity information is not considered. Improved quality and interpretability of the discovered putative driver gene sets compared to existing methods shows that QuaDMutNetEx is a valuable new tool for detecting driver genes. QuaDMutNetEx is available for download from https://github.com/bokhariy/QuaDMutNetExunder the GNU GPLv3 license.